Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Foreword
Dear Doctor, “Essential drugs are those that satisfy the health care needs of the majority of the
population; they should therefore be available at all times in adequate amounts and in
the appropriate dosage forms, and at a price that individuals and the community can
afford”.
Careful selection of a limited range of essential medicines results in a higher quality of care,
better management of medicines (including improved quality of prescribed medicines),
and more cost-effective use of health resources”
(WHO Expert Committee on the Use of Essential Drugs, 1999).
Many states in India including Karnataka, Kerala, Himachal Pradesh, Delhi, Maharashtra and
Rajasthan have prepared their essential drug lists. The Government of Chhattisgarh also has taken
the initiative to prepare and adopt the Essential Drug List for Chhattisgarh (EDLC). The relevant
Government Orders are enclosed.
The Basic Goals of the ELD Chhattisgarh are:
To ensure the availability and accessibility of essential drugs to all citizens of
Chhattisgarh;
To ensure safety, efficacy and quality of drugs in the public health system;
To encourage and support good prescribing and dispensing practices;
The Process: The Department of Health & Family constituted a committee headed by the Director,
Medical Education with the Director Health Services and the Dean of the Medical College as
members to draw up theEDL Chhattisgarh. In turn, this committee, with the technical assistance of
the State Health Resource Centre, Chhattisgarh set up one day three intensive consultation with
senior medical professionals, the faculty of Raipur Medical College, NGOs active in the health field,
and senior departmental officials. The State Advisory Committee also gave valuable inputs to this
process. Experts in rational drug policy from other states were also invited to this consultation. The
W H O Model List for the year 2015, NELM of 2015, British National Formulary 2009 and National
Drug Formulary 2011 were used as the base papers for this discussion in finalising theEDL
Chhattisgarh.
Selection of Essential medical list
The process by which medicines are selected is critical. An essential medicines list which is
imposed from above will not reflect the need of the users or be accepted by them. It is therefore
very important that the process be consultative and transparent, selection criteria be explicit,
selection of the medicines be linked to evidence-based standard clinical guidelines, clinical
guidelines and the list be divided into levels of care, and are regularly reviewed and updated. A
review of the clinical guidelines and the list should be carried out at least every second year, and
their use and the impact should be monitored. The process of developing a list of essential drug list
is mentioned below.
The Criteria: The principal criteria for the selection of essential drugs for primary, secondary and tertiary hospital care were based on the WHO guidelines for drawing up an EDL. They include the following points:
Any drug included must meet the needs of the majority of the population;
Sufficient proven scientific data regarding effectiveness must be available;
Any drug included in the EDL should have substantial safety and benefit/ risk ratio;
All products must be of acceptable quality, and must be tested on a continuous basis;
The aim, as a rule, is to include, only products containing single pharmacologically active ingredients;
Combination products, as an exception, will be included where patient compliance becomes an important factor or where two pharmacologically active ingredients are synergistically active in a product;
Products will be listed according to their generic names only;
Where drugs are clinically equally effective, the dugs will be compared on the following factors: 1. The best cost advantage, 2. The best researched, 3. The best pharmaco kinetic properties, 4. The best patient compliance.
Grading of the Essential Drug List: The EDL Chhattisgarh is published in two parts, first part consist
of list of drugs which are essentially required at primary, secondary and tertiary level of medical
facilities. Second part is drugs which are required at specialty centers and are prescribed by
specialists with extra attention. The main EDL Chhattisgarh covers the needs of all public health
facilities excepting the medical college. It is graded to indicate drugs that shall be supplied to all
health centers and those that are restricted to Primary, secondary and tertiary level medical
facilities.(which includes PHC, community health centers and District Hospitals).
Depending on the specialist and equipment available in each health care institution these facilities
would specify their drug requirements from within this list. The list of drugs for the Medical College
Hospital (tertiary care), was prepared by the faculty of the college and is published as a
supplementary list. Another supplementary list (Universal category) specifies the drugs that would
be made available to the multipurpose health workers –both male and female. While grading the list
we have kept in mind the specific demands of Chhattisgarh given the distances and problems in
transport and the fact that referral to higher centers is not easy. The broad principle followed is to
provide as comprehensive a care as possible, made available as peripherally as possible - given
the human resource and infrastructure available at that level. All drug purchase made by the
Government of Chhattisgarh would have to comply with the EDL Chhattisgarh.
Amendment of EDL/ Adding a New Product on EDL Chhattisgarh: We recognize that a good drug
policy requires to EDL Chhattisgarh dynamic and updated periodically. We welcome suggestions
towards this. Requests for products to be included on the EDL Chhattisgarh must conform to the
above criteria and must be supported by evidence-based data and appropriate references on its
advantages and benefits over existing products. A format for such requests has been given as
been appended.
The Department of Health and Family Welfare will be appointing a Committee to monitor the
implementation of the EDL Chhattisgarh and make periodic revisions of the list. An essential drug
formulary, and a graded standard treatment protocol as well as mechanisms to train various
categories of staff and promote the use of the list would be in place soon. Other supporting systems
to ensure safe and adequate essential drug supply to every citizen of Chhattisgarh are in our plans.
I hereby express my sincere thanks to all those experts, the medical community of Chhattisgarh
and the concerned NGO representatives whose valid contributions paved way to the EDL
Chhattisgarh and its publication. I hope the medical community of the state will welcome and
nourish this move as this is the threshold point towards a comprehensive and rational drug policy
for the state.
Sincerely Yours,
Vikas Sheel
Secretary to Government of Chhattisgarh
Department of Health & Family Welfare.
Acknowledgements
Even small efforts raise large debts. For the finalisation of the Essential Drug List of
Chhattisgarh, we are indebted to a number of individuals and organisations. The committee
appointed by the Department of Health & Family Welfare led by the Dr Shashank Gupta,
HOD, Medicine JNMCH Medical College Hospital Raipur. Dr. S K Shandilya came up with
the idea of holding a workshop for finalizing the Essential Drug List and charting out the
broad contours of the State Drug Policy. Dr. A K Chandrakar, Dean, Jawaharlal Nehru
Memorial Medical College, Raipur not only made valuable contributions to the consultation
but also enthused the senior faculty of this primer institution to attend and contribute to the
deliberations in meetings. Director, Health Services, ensured the participation of his colleagues
and has supported this process since its inception.
Dr Rajesh Rishikar, Dr G P Soni, Dr Smt S Phuljhele, Dr K K Sahare, Dr S Phuljhele, Dr P
Beck, Dr R R Sahni, Dr Pratibha Jain Shah, Dr Nalini Mishra, Dr rajesh Sharma, Dr J P
Meshram, Dr Prashant Srivastav, Dr B K Das, Dr S P Kujur, Dr S A Khan, Dr V B Verma, Dr
S Gupta, attended the sessions.
The State Advisory Committee has helped in the broadening of the mandate of the changes
being undertaken in the health sector in Chhattisgarh and provided the much-needed
perspective for this effort.
Narayan Tripathi, Fidius Kerketta and Dr Prabir Chatterjee from State Health Resource
Centre undertook the logistics and co-ordination of the workshop and courteously
accommodated every demand made of them during and after the workshop.
Lastly, much of the efforts towards community basing of health services in Chhattisgarh
would not have been possible without the strong endorsement, conviction and belief of Dr
Ayyaz F Tamboli and Avinash Chamapavat IAS who were MD NHM when this work was in
progress.
R Prasanna
Director Health Services,
Department of Health & Family Welfare
ESSENTIAL DRUGS LIST PART I
CONTENTS
PART – A
1. ANAESTHETICS
2. ANALGESICS, ANTIPYRETICS, NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIDS), MEDICINES
USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS USED IN RHEUMATOLD DISORDERS
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
5. ANTICONVULSANTS / ANTIEPILEPTICS
6. ANTI INFECTIVE DRUGS
7. ANTIMIGRAINE MEDICINES
8. ANTINEOPLASTIC IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
9. ANTIPARKINSONS MEDICINE
10. MEDICINES AFFECTING THE BLOOD
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
12. CARDIOVASCULAR MEDICINES
14. DERMATOLOGICAL MEDICINES (topical)
15. DIAGNOSTIC AGENTS (enlisted in section of Surgical and suture list)
16. PERITONEAL DIALYSIS SOLUTION– restricted to tertiary care center where peritoneal dialysis is undertaken
17. DISINFECTANTS AND ANTISEPTICS
18. DIURETICS
19. EAR, NOSE AND THROAT PREPARATIONS
20. GASTROINTESTINAL MEDICINES
21. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
22. IMMUNOLOGICALS
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
24. SPECIFIC MEDICINES FOR NEONATAL CARE
25. OPHTHALMOLOGICAL PREPARATIONS
26. OXYTOCICS AND ANTIOXYTOCICS
27. PSYCHOTHERAPEUTIC MEDICINES
28. MEDICINES ACTING ON THE RESPIRATORY TRACT
29. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
30. VITAMINS AND MINERALS
PART-B
SURGICAL, DIAGNOSTIC AGENTS AND SUTURE LIST 1. ABSORBABLE SUTURES
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
3. POLYGLECAPRON SUTURES
4. POLYDIOXANONE SUTURES
APPENDIX
1. Format to Amend the Essential Drug List for Chhattisgarh
2. Adverse Drug Reaction Reporting Form http://ipc.nic.in http://cdsco.nic.in/pharmacovigilance.htm
3. List of Participants
4. Universal Category List
5. Primary Category List
6. Secondary Category List
7. Specialist Category List
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Halothane Inhalation S 250ml Bottle D253
50 mg/ml in 2ml Vial 2ml Vial D297
50 mg/ml in 10ml
Vial
10ml Vial D298
Nitrous oxide Inhalation S Cylinder D372
Oxygen Inhalation P Cylinder D392
0.5 g D503
1.0 g D504
Isoflurane Inhalation (Vaporiser) T 100 ml Bottle D286
Sevoflurane Inhalation (Vaporiser) T 250ml PEN Bottle D471
Propofol Injection 1% S 20ml vial D439
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
0.25% in vial D80
0.5% in vial D81
Injection for Spinal
Anaesthesia
0.5% in 4-ml
ampoule to be mixed
with 7.5% glucose
solution
P 4ml Ampoule D82
1% 30ml vial D307
2% 30ml vial D308
Injection for Spinal
Anaesthesia
5% to be mixed with
7.5% glucose
solution
2ml ampoule D309
Jelly (Topical) 2% S 30gm tube D310
Viscous Solution (Topical) 4% P 30ml D311
Injection 1%+ epinephrine
1:200 000
30ml vial D313
Dental Cartridge 2% + epinephrine
1:80 000 in 2.2ml
cartridge
50ml vial D314
Glycopyrrolate USP Injection 0.2mg/ml S 1ml ampoule D248
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 1mg 10 x 10 D55
Injection 0.6 mg/ml 2ml ampoule D56
Injection 5 mg/ml 2ml ampoule D164
Tablet (Scored) 5 mg 10 x 10 D165
Morphine (Sulphate or
hydrochloride)
Injection 10 mg S 1ml ampoule D358
Promethazine Hydrochloride Syrup 5 mg/5 ml P 60ml bottle D437
Fentanyl Citrate Injection 0.05mg/ml T 2ml ampoule D217
Midazolam Injection 1mg/ml T 5ml vial D350
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
75 mg 10 x 10 D2
150 mg 10 x 10 D3
325 mg 10 x 10 D4
200 mg 10 x 10 D271
400 mg 10 x 10 D272
Suspension 100mg/5ml 60ml bottle D273
Tablet 500 mg 10 x 10 D395
Syrup 125 mg/5ml 60ml bottle D396
Suppository 250mg P 5 suppository D397
Paracetamol Injection IM S 2ml D395A
Tablet 50mg 10 x 10 D168
Tablet 50mg 10 x 10 D608
Injection 25mg/ml PG
surfactant free
3ml ampoule D170
Gel 1% w/v 25 gm tube D171
Suppository 50mg S 5 suppository D607
Tablet 10mg 10x10 D675
Injection 15mg/ml 1 ml D676
Paracetamol suppository 80 mg P 5 suppository D711
Aceclofenac Tablet 100mg T(R) ND21
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Morphine (Sulphate or
hydrochloride)
Injection 10 mg/ml T 1ml ampoule D358
Pentazocine Injection 30mg/ml S 1ml ampoule D398
1. ANAESTHETICS
1.1 General anaesthetics and oxygen
1.2 Local anaesthetics
1.3 Preoperative medication and sedation for short-term procedures
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIDs)
2.2 Opioid analgesics
Thiopentone sodium Injection S 50 ampoules
Bupivacaine hydrochloride Injection P 20ml Vial
Lidocaine hydrochloride Injection P
Ketamine hydrochloride Injection
S
2. Analgesics, Antipyretics, Nonsteroidal Anti-inflammatory Medicines (NSAIDs),
Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders
Lidocaine hydrochloride +
Epinephrine (adrenaline)
S
Atropine Sulphate
Diazepam
S
P
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) P
Ibuprofen Tablet P
Paracetamol U
Diclofenac sodium P
Ketorolac S
ESSENTIAL DRUG LIST -2016
-
-
-
Injection 50mg/ml 5x1ml D753
Tablet 50mg 10x10 D754
Buprenorphine Patch 5mcg T ND13
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Allopurinol Tablet 100mg T 10 x 10 D16
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydroxy Chloroquine (as
phosphate or sulphate)
Tablet 150 mg (base) S 10 x 10 D266
2.5mg 10 x 10 D335
7.5 mg 10x10 D685
Sulfasalazine Tablet 500 mg S 10 x 10 D493
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Injection 10 mg/ml 1ml ampoule D115
Tablet 4 mg 10 x 10 D116
Oral Solution Syrup 2mg/5ml D117
Pheniramine Injection 2ml P ampoule D115A
Dexamethasone Injection 4 mg/ml P 2ml ampoule D157
Epinephrine Hydrochloride
(Adrenaline)
Injection 1 mg/ml U 1ml ampoule D199
Hydrocortisone sodium
succinate
Powder for Injection 100 mg P Vial D261
10mg 10 x 10 D427
20mg 10 x 10 D428
Liquid 5mg/5ml 120ml bottle D429
Tablet 4 mg T D689
Injection 40mg/ml T Vial D336
Tablet 25mg T 10 x 10 D121
Syrup 5mg/ml P D583
Fluticasone Nasal spray 120 metered dose S D642
Hydroxyzine Syrup 10 mg/5ml S D662
Hydroxyzine Injection 25mg S 10 x 10 D662A
Levo-Cetrizine Tablet 5 mg P D683
Cetrizine Tablet 5 mg P D683A
Deflazacort Tablet 6mg T(R) ND25
Budesonide Respules T ND8
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Active Charcoal Powder P D5
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atropine Sulphate Injection 0.6 mg/ml P 2ml ampoule D56
Calcium gluconate Injection 100 mg/ml P 10ml ampoule D84
Pralidoxime Injection 25mg/ml P 20ml Vial D426
Neostigmine Metilsulfate Injection 500 micrograms S 1ml ampoule D364
250mg T D609
500mg T D610
Tablet 1mg S D717
Tablet 2mg S D718
Injection 500mg T D602
Tablet 500mg T D603
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
200 mg 10 x 10 D86
400 mg 10 x 10 D87
Syrup 20 mg/ml 100ml bottle D88
Injection 5 mg/ml S 2ml ampoule D164
Tablet (Scored) 5 mg 10 x 10 D165
Suppository 5mg 1x5 D166
Suspension 2mg/5ml 60ml Bottle D167
Magnesium sulphate Injection 500 mg/ml U 10ml ampoule D321
30mg 10 x 10 D402
60mg 10 x 10 D403
Syrup 20mg/5ml P 60ml bottle D404
Injection 200mg/ml T 1ml ampoule D405
Tablet 100 mg 10 x 10 D408
Injection 50 mg/ml 5ml vial D409
200mg 10 x 10 D514
2.3 Medicines used to treat gout
2.4 Disease modifying Agents used in Rheumatoid Disorders (DMARDs)
Diazepam
P
Phenobarbitone Tablet P
Phenytoin Sodium P
Tablet (Control Release) SValproic acid (Sodium salt)
Cinnarzine
Methylprednisolone
Disulfiram Tablet
Prazocin
Deferasirox
Carbamazepine Tablet (Control Release) S
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non Specific
4.2 Specific
5. ANTICONVULSANTS/ANTIEPILEPTICS
S
Methotrexate Sodium Tablet T
Chlorpheniramine P
Prednisolone Tablet P
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
Tramadol
500mg 10 x 10 D515
Liquid Oral Solution 200mg/5ml 100ml bottle D516
Injection 100 mg/ml T 5 ml D760
Midazolam Injection 1mg/ml T 5ml vial D350
Tablet 1mg 10 x 10 D318
Injection 4mg 2ml ampoule D319
Clobazam Tablet 10mg T ND4
Levetiracetam Tablet 500mg T ND5
Pregabalin Tablet 75mg T(R) ND27
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet (Chewable) 400 mg Single dose pack D12
Suspension 200mg/5ml 10ml bottle D13
Tablet 100mg 6 tab x 10 D324
Suspension 100mg/5ml 30ml bottle D325
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
50mg 10 x 10 D174
100 mg 10 x 10 D175
Ivermectin Tablet (Scored) 6mg T 1 tab x 10 D296
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
250 mg 10 x 10 D28
500 mg 10 x 10 D29
Powder for Oral
Suspension
125 mg/5 ml 30ml bottle D30
Tablet 125mg 10x10 D560
Ampicillin Sodium Powder for Injection 1gm P Vial D41
Benzathine benzyl penicillin Powder for Injection 1.44 g
benzylpenicillin (=2.4
million IU)
P 5ml vial D66
Benzyl penicillin(sodium or
potassium salt)
Powder for Injection 600 mg (= 1 million
IU)
P Vial D71
Capsule 500 mg 10 x 10 D133
Powder for Oral Solution 125 mg/5 ml 30ml bottle D135
250mg 10 x 10 D95
500mg 10 x 10 D96
125mg/5ml 30ml bottle D97
250mg/5ml 30ml bottle D98
250mg T Vial D104
1gm S 30ml Vial D105
250mg Vial D102
1gm Vial D103
Imipenem Monohydrate +
Cilastatin Sodium
Powder for Injection 250mg + 250mg T Vial D274
125mg + 31.25mg
(156mg)/5ml
S 30ml bottle D31
250mg + 62.5mg
(312mg)/5ml
S 30ml bottle D32
250mg +50mg
(300mg)
Vial D33
500mg + 100mg
(600mg)
Vial D34
1gm + 200mg (1.2
gm)
Vial D35
250mg + 125mg
(375mg)
S 6 tab x 10 D36
500mg + 125mg
(625mg)
S 6 tab x 10 D37
Syrup 50 mg/5ml 30 ml D581
Tablet 200 mg 10x10 D582
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
250 mg 10 x 10 D122
500 mg 10 x 10 D123
Infusion 2mg/ml S 100ml D124
Doxycycline Hydrochloride Capsule 100 mg P 10 x 10 D192
250 mg 10 x 10 D202
Cefpodoxime
Ciprofloxacin Hydrochloride Tablet P
Erythromycin Stearate Tablet or Capsule S
6.2.2 Other antibacterial
T
Ceftazidime Injection T
Amoxicillin + Clavulanic acid Suspension
Injection
Tablet
S
PAmoxicillin anhydrous
Cloxacillin Sodium S
Cefalexin Tablet or Capsule
Oral Solution
S
S
Ceftriaxone Sodium Powder for Injection
Tablet or Capsule
6.1.2 Anti-filarials
6.2.1 Beta Lactam medicines
Mebendazole
U
S
Diethyl carbamazine citrate Tablet P
Tablet (Control Release) S
Lorazepam
Valproic acid (Sodium salt)
T
Albendazole
6. ANTI INFECTIVE DRUGS
6.1 Anti-helminthes
6.1.1 Intestinal anthelminthics
500mg 10 x 10 D203
Powder for Oral
Suspension
125 mg/5ml 60ml bottle D204
250 mg 6 tab x 10 D60
500mg 6 tab x10 D61
Syrup 100 mg/5ml S 15ml bottle D62
10 mg/ml P 2-ml vial D242
40 mg/ml P 2-ml vial D243
Tablet 200mg 10 x 10 D344
Infusion/ Injection 500 mg 100ml bottle D346
Metronidazole Benzoate Oral Suspension 200 mg/5 ml P 60ml bottle D347
200 mg + 40 mg 10 x 10 D490
400 mg + 80 mg 10 x 10 D491
Oral Suspension 200 mg + 40 mg/5
ml
60ml bottle D492
Cefadroxyl Tablet 250mg T 10 x10 D92
Cefadroxyl Tablet 500mg T 10 x 10 D93
Cefadroxyl Syrup 125mg/5ml T 30ml bottle D94
Amikacin Injection 100mg/2ml T Vial D19
Amikacin Injection 250mg/2ml T Vial D20
Amikacin Injection 500mg/2ml T Vial D21
Vancomycin Hydrochloride Powder for Injection 250mg T Vial D517
Vancomycin Hydrochloride Powder for Injection 500mg T Vial D518
Cefixime Capsule 100mg T 10 x 10 D99
Cefixime Capsule 200mg T 10 x 10 D100
Cefixime Dry Syrup 50mg/5ml T 30ml bottle D101
1gm 5 ml Vial D864A
500mg 5 ml Vial D684
Netilmicin Injection 10mg T 5 ml Vial D701
Netilmicin Injection 50mg T 5 ml Vial D702
Piperacillin+Tazobactam Injection 4.5gm T ND9
colistin Powder for injection 1mu/vial T ND10
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
50 mg D128
100 mg 10 x 10 D129
25 mg 10 x 10 D147
50 mg 10 x 10 D148
100 mg 10 x 10 D149
150 mg 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
200mg 10 x 10 D378
400mg 10 x 10 D379
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
400 mg 10 x 10 D629
200 mg 10 x 10 D630
800 mg 10 x 10 D205
100mg 10 x 10 D287
300 mg 10 x 10 D288
500 mg 10 x 10 D445
750 mg 10 x 10 D446
150 mg 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
Streptomycin Sulphate Powder for Injection 1 g P Vial D485
Cycloserine Tablet 250mg P 10 x 10 D596
Ethionamide Tablet 250mg S 10 x 10 D634
500mg 10 x 10 D673
1000mg 10 x 10 D674
Linezolid 300ml bottle 2mg/ml T ND16Levofloxacin Tablet 500mg T(R) ND17
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Amphotericin B lipholised Powder for Injection 50 mg T Vial D38
150 mg D225
200 mg D226
Injection 2 mg/ml P Vial D227
Oral Suspension 50 mg/5-ml P D228
Oral Solution 50mg/5ml (100000
IU/ml)
D376
Lozenge 100000 IU D377
Povidone Iodine Vaginal Passaries 200mg S 10 passaries D425
Ear Drops 1% W/V 10ml D130
Meropenem Injection T
6.2.3 Antileprosy medicines (Antileprosy and antitubercular drugs should be provided as per national programme)
6.2.4 Antituberculosis medicines
6.3 Antifungal medicines
P
P
P
S
Isoniazid Tablet
Pyrazinamide Tablet
Rifampicin
Kanamycin
Tablet or Capsule
Tablet
Gentamicin Sulphate Injection
Metronidazole P
Sulphamethoxazole +
Trimethoprim
Tablet P
T
Clotrimazole S
Ethambutol Hydrochloride Tablet P
Fluconazole Capsule
Erythromycin Stearate Tablet or Capsule S
Azithromycin Tablet P
Single dose pack/ 10 x
10
Nystatin
P
Clofazimine Capsule P
Dapsone Tablet P
Rifampicin Tablet or Capsule P
Ofloxacin Tablet T
Mouth Paint 1% W/V D131
Cream 2% W/W P 15gm tube D132
Benzoic acid compound
(Benzoic acid + Salicylic acid)
Ointment (6%+ 3% ) T 15gm tube D67
Ointment 1%w/w+0.025%w/w 10g Tube D591
Ear Drops 1%w/v+2%w/v D592
Clindamycin+clotrimazole Vaginal Tablet 100mg+100mg P 1x6 tab D587
Metronidazole Vaginal gel Vaginal Gel 0.75% P 5gm D690
caspofungin Powder for injection 50mg,70mg T ND11
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 200 mg 10 x 10 D6
Oral Solution 200mg/5ml 60ml bottle D7
Ophthalmic Ointment 0.03 5gm tube D9
Powder for Injection 250 mg 10ml Vial D10
Tablet 800mg 10x10 D559
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
100 mg 10 x 10 D536
250 mg 10 x 10 D537
Tablet 300 mg 10 x 10 D538
Oral Liquid 50 mg/5 ml 100ml bottle D539
IV or Infusion Injection 10mg/ml 20ml Vial D540
Stavudin+Lamuvidin Tablet 30mg+150mg T 10x10 D737
Zidovudine +Limuvidin+
Nevirapine
Tablet 300mg+150mg+200
mg
S 10x10 D762
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Capsule 30 mg 10 x 10 D388
Capsule 45 mg 10 x 10 D389
Capsule 75 mg 10 x10 D390
Syrup 100ml bottle 10x10 D707
Dry Powder for Oral
Suspension
12 mg/ml 75ml bottle D391
Tablet 200mg 10 x 10 D363
Oral Suspension 50mg/5ml 100ml D364
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
200mg P 10 x 10 D344
400mg U 10 x10 D345
Injection 500 mg P 100ml vial D346
Oral Suspension 200 mg/5 ml P 60ml bottle D347
500mg 10 x 10 D507
1gm 10 x10 D508
Nitazoxamide Syrup 100mg/5ml P 30 ml D704
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Artemether Injection 80 mg/ml S 1ml ampoule D47
Artesunate Injection 60mg P 2ml ampoule D50
Injection 40 mg/ml P 5ml ampoule D112
Tablet 150 mg base 10 x 10 D113
Syrup 50 mg /5ml 60ml bottle D114
7.5 mg 10 x 10 D432
2.5 mg 10 x 10 D433
Tablet 300 mg 10 x 10 D448
Oral Solution 150mg/5ml 60ml Bottle D449
Injection 300 mg/ml 2ml ampoule D450
Tablet (Pink Colour) 0-1 year
(AS:25mg,SP:125m
g+6.25mg)
Combi pack for full
course (3 days)
D555U
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
6.4.2 Anti retrovirals Medicine
6.4.2.1 Nucleoside reverse transcriptase inhibitors-T ART (to be provided by NACO)
6.4.3 Other antivirals
6.5 Antiprotozaol Medicines
Nevirapine T
Acyclovir
Metronidazole
6.5.3 Antimalarial medicines (as per National Programme Guideline)
6.5.3.1 For curative treatment
Clotrimazole S
Clotrimazole+ Steroid P
S
Zidovudine Capsule S
Oseltamivir T
6.5.1 Antiamoebic and antigiardiasis medicines
6.5.2 Antileishmaniasis medicines
Tablet
Tinidazole Tablet S
Chloroquine (as hydrochloride,
phosphate or sulphate)
Primaquine
Diphosphate/Phasphate
Tablet U
U
Quinine (bisulphate or
sulphate)
P
ACT combi Blister Pack
Tablet (Yellow Colour) 2-4 year
(AS:50mg,SP:500m
g+25mg)
Combi pack for full
course (3 days)
D558
Tablet(Green Colour) 5-8 year
(AS:100mg,SP:750
mg+37.5mg)
Combi pack for full
course (3 days)
D554
Tablet (Red Colour) 9-14 year
(AS:150mg,SP:500
mg+25mg)
Combi pack for full
course (3 days)
D556
Tablet (White Colour) 15 year & above
(AS:100mg,SP:750
mg+37.5mg)
Combi pack for full
course (3 days)
D557
Artether Injection 150mg P 2 ml x 3 D562
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
0.5 D176
0.75 D177
Synthetic pyrethroid WP As per NVBDCP
Supply
U D496
DDT Powder As per NVBDCP
Supply
U D151
Deltamethrin Solution 2.50% U D153
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) 325 mg P 10 x 10 D4
Paracetamol Tablet 500 mg P 10 x10 D395
Clonidine injection 150mg/ml T ND15
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
10 mg 10 x10 D440
40 mg 10 x 10 D441
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bortezomib IP Injection 2 mg T(R) Vial D571
Carboplatin IP Injection 150 mg T(R) Vial D579
Carboplatin IP Injection 450mg T(R) Vial D580
Cisplatin Injection 10mg/10ml T(R) Vial D127
Cyclophosphamide Injection 200mg T(R) 30ml vial D144
Cyclophosphamide Injection 500mg T(R) Vial D595
Docitaxel IP Injection 20 mg with Solvent T(R) Vial D612
Docitaxel IP Injection 80 mg with Solvent T(R) Vial D613
Doxorubicin Injection 10mg/5ml T(R) 5ml Vial D191
Florouracil Injection 250mg T(R) 5ml ampoule D224
Hydroxyurea Capsule 500mg T(R) 10 x 10 D268
Methotrexate Tab./Injection 5mg T(R) 10 D685
Methotrexate Injection 10mg T(R) Vial D686
Methotrexate IP (preservative free) Injection 15 mg T(R) Vial D688
Erythropoietin IP Injection 10000 units T(R) Vial D624
Erythropoietin IP Injection 40000 units T(R) Vial D624A
Tamoxifen Injection 20mg T(R) Vial D742
Tamoxifen Injection 10mg T(R) Vial D742A
Oxaliplatin IP Injection 100 mg T(R) Vial D708
Oxaliplatin IP Injection 50 mg T(R) Vial D709
Bicalutamide Tablet 50 mg T(R) 10 D568
Bleomycin Injection 15mg T(R) Vial D79
Capecitabine Capsule 500 mg T(R) 10 D578
Chlorambucil Capsule 5mg T(R) 10 tablet packs/10 x 10D107
D actinomycin Injection 0.5mg T(R) Vial D146
Daunorubicin IP Injection 20 mg T(R) Vial D600
Etoposide Capsule 100mg T(R) 4cap. Pack/4cap.x 10 D213
Etoposide Injection 100mg/5ml T(R) 5ml Vial D214
Ifosphamide IP Injection 1gm T(R) Vial D666
L.Asparaginase IP Injection 10000 units T(R) Vial D678
Mercaptopurine Tablet 50mg T(R) 10 x 10 D332
Paclitaxel IP Injection 260 mg with solvent T(R) Vial D710
Procarbazine Capsule 50mg T(R) 10 x 10 D434
Rituximab Injection 10mg/ml T(R) Vial D729
Temozolomide Capsule 100mg T(R) 10 D745
Temozolomide Capsule 250mg T(R) 10 D746
Temozolomide Injection 20mg T(R) 10mg D747
Thalidomide Tablet 100 mg T(R) 10 D748
Trastuzumeb Injection 440 mg T(R) Vial D756
Vinblastine Injection 10mg T(R) Vial D522
Vincristine Injection 1 mg T(R) Vial D523
Cytarabine Injection 500mg T(R) 5ml Vial D145
Cytarabine Injection 100mg T(R) 5ml VialGranisetron IP Tablet 1mg T(R) 10 D656
U
Diethyltoluamide Cutaneous Solution P
Propranolol Tablet S
6.6. Insect repellant
7. ANTIMIGRAINE MEDICINES
7.1 For acute attack
7.2 For prophylaxis
8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
ACT combi Blister Pack
Granisetron IP Injection 3mg T(R) Ampoule D657
Idarubicin IP Injection 10 mg T(R) Vial D665
Irinotecan IP Injection 100 mg T(R) Vial D671
Leucovarin IP Injection 50 mg T(R) Vial D682
Nenotaxel IP Injection 100 mg T(R) Vial D698
Nenotaxel IP Injection 300mg T(R) Vial D699
Pemetrixate IP Injection 500 mg T(R) Vial D712
Pemetrixate IP Injection 100mg T(R) Vial D713
Busulfan Capsule 2mg T(R) 10 x 10 D83
Dacarbazine Injection 200mg T(R) ND7
Dacarbazine Injection 400mg T(R)
Arsenic trioxide Injection 1mg/ml T(R) ND31
Calcium folinate Tab 15mg T(R) ND32
Calcium folinate Injection 3mg/ml T(R) ND32A
Mesna Injection 100mg/ml T(R) ND33
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Trihexyphenidyl Hydrochloride Tablet 2 mg S 10 x 10 D511
Tablet 100 mg + 10 mg 10 x 10 D301
Tablet (Control Release) 250 mg + 25 mg 10 x 10 D302
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ferrous Fumarate Drop 5mg/ml U 10 x 10 (Enteric Coated
)
D218
Tablet 100 mg elemental
iron
10 x 10 D219
Oral Solution equivalent to 25 mg
iron
D220
Dried Ferrous
Sulphate IP eq. to
Ferrous Iron 100 mg
& Folic Acid IP 0.5
mg (Red Colour)
10 x 10 D221SU
Dried Ferrous
Sulphate IP eq. to
Ferrous Iron 100 mg
& Folic Acid IP 0.5
mg (Blue Colour)
10 x 10 D221
equivalent to 20 mg
iron + 0.1mg folic
acid
10 x 10 D222
Syrup equivalent to 20 mg
Iron + 0.1mg Folic
acid per 1ml in bottle
U 10 x 10 D223
1mg D232
5mg D233
400mcg
Injection 1 mg 1ml ampoule D234
Hydroxocobalamin Injection 1 mg S D265
50mg D284
100mg 10 x 10 D285
500mg D268
250mg D661
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
1000 IU/ml 1ml ampoule D254
5000 IU/ml 1ml ampoule D255
20000 IU/ml 1ml ampoule D256
Injection 10 mg/ml 5ml ampoule D410
Tablet 10 mg D411
Protamine Sulphate Injection 10 mg/ml S 5ml ampoule D444
1 mg 10 x 10 D530
5 mg 10 x 10 D531
Vitamin K Injection 1mg/ml T 1ml ampoule D528
Vitamin K1 Injection 1mg/ml T (R) 1ml ampoule D529
Streptokinase Injection 15,00,000 IU T Vial D484
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydroxyethyl Starch Injection 6% S 500ml D267
Tablet 500mg 10 x 10 D509
Injection 500mg/5ml 5ml ampoule D510
Ferrous Sulphate U
Ferrous Sulphate + Folic Acid Tablet U
Heparin Sodium Injection S
10.2 Medicines affecting coagulation
Levodopa + Carbidopa S
Folic Acid
10.1 Antianaemia medicines
Iron Sucrose Injection S
Hydroxyurea Capsule S
PTablet
9. ANTIPARKINSONS MEDICINE
10. MEDICINES AFFECTING THE BLOOD
Phytomenadione S
Warfarin Sodium Tablet (Score) S
Tranexamic Acid T
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11.1 Plasma substitutes
11.2 Plasma fractions for specific use –T
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
20% in 50ml D14
20% in 100ml D15
Cryoprecipitate Injection T D142
Factor IX Complex
(Coagulation factors II,VII,IX X)
Injection Dried T D215
Factor VIII Concentrate Injection Dried T D216
Platelet Rich Plasma Injection T D415
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
5 mg S 10 x 10 D289
10 mg P 10 x 10 D290
5 mg 10 x 10 D291
10 mg 10 x 10 D292
75 mg 10 x 10 D2
150 mg 10 x 10 D3
Verapamil Hydrochloride Tablet 40 mg T 10 x 10 D520
Injection 25mg T 5ml ampoule D371
2.6mg 10x10 D654
6.4mg 10x10 D655
Clopidogrel Tablet 75mg T 10x10 D589
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atenolol Tablet 50 mg P 14 x 10 D52
Tablet 250 mcg 10 x 10 D178
Oral Solution 50 mcg/ml 30ml D179
Injection 250 mcg/ml 2ml ampoule D180
Lidocaine Hydrochloride Injection 20 mg/ml
(preservative free)
S 5ml ampoule D312
Tablet 40 mg T 10 x 10 D520
Injection 2.5 mg/ml S 2ml ampoule D521
Tablet 200mg 10 x 10 D23
Injection 150mg 3ml vial D24
Tablet 30mg 10 x 10 D181
Injection 30mg Vial D182
Adenosine Injection 3mg/ml T 2ml ampoule D11
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
50 mg 14 x 10 D52
25 mg 14 x 10 D53
2.5 mg 10 x 10 D197
5 mg 10 x 10 D198
Tablet (Scored) 25 mg 10 x 10 D259
Tablet 50 mg 10 x 10 D260
Hydrochlorothiazide Tablet 12.5mg P 10 x 10 D260A
Methyldopa Tablet (Film Coated) 250 mg S 10 x 10 D337
Capsule 5 mg 10 x 10 D366
10 mg 10 x 10 D367
20 mg 10 x 10 D368
Mephenteramine Injection 30mg/ml T 10ml Vial D331
Nor adrenaline Injection 4mg/2ml S 2ml ampoule D373
25mg 10 x 10 D341
50mg 10 x 10 D342
Injection 1mg/ml T 5ml ampoule D343
Tablet 100mg 10 x 10 D299
Injection 10mg/ml 20ml vial D300
20mg 10x10 D743
40mg 10x10 D744
2.5mg 10x10 D730
5mg 10x10 D731
Amlodipine Tablet 5mg T 10x10 D731A
Sodium Nitropruside Injection 5ml T 5ml Vial D735
Olmesartan Tablet 20mg T(R) ND26
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
2.5 mg 10 x 10 D197
5 mg 10 x 10 D198
Tablet 250 mcg 10 x 10 D178
Oral Solution 50 mcg/ml 30ml D179
Injection 250 mcg/ml 2ml ampoule D180
Dopamine Hydrochloride Injection 40 mg S 5ml vial D190
Tablet (Scored) 25 mg 10 x 10 D259
Tablet 50 mg 10 x 10 D260
Isosorbide Dinitrate Tablet (Sublingual)
Glyceryl Trinitrate
Tablet S
Digoxin S
Verapamil Hydrochloride
Amiodarone T
Diltiazem T
Atenolol Tablet P
Enalapril Tablet (Scored) S
Hydrochlorothiazide
Telmisartan Tablet S
S-Amlodipine
12.1 Antianginal medicines
12.2 Antiarrhythmic medicines
Isosorbide Monoinitrate Tablet (Sublingual) T
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) P
Albumin Injection T
12. CARDIOVASCULAR MEDICINES
P
Nifedipine
Tablet (Sustained
Released)
Metoprolol Tablet S
Labetalol S
P
12.3 Antihypertensive medicines
Tablet T
Enalapril
Digoxin
Hydrochlorothiazide
Tablet (Scored) S
S
P
12.4 Medicines used in heart failure
Dobutamine Injection 50 mg /ml T 5ml ampoule D187
Tablet 40mg 10 x 10 D239
Injection 10 mg/ml 2ml ampoule D240
2.5 mg 10x10 D726
5mg 10x10 D727
Carvedilol Tablet 3.125mg T(R) ND23
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Methyldopa Tablet 250 mg/500mg P 10 x 10 D337
Magnesium Sulphate Injection 500 mg/ml U 10ml ampoule D321
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atorvastatin Tablet 10 mg 10x10 D563
20mg 10x10 D564
40mg 10x10 D564A
Fenofibrate Tablet 300mg T 10x10 D635
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Miconazole Nitrate Ointment or Cream 2% P 15gm tube D349
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acyclovir Cream 5% S 15gm tube D8
Framycetin Sulphate Cream 0.50% U 5gm or 15gm tube D235
Solution 5% 500ml bottle D422
Ointment 5% 15gm tube D423
Neomycin Sulphate +
Bacitracin Zinc
Ointment 5 mg + 500 IU/gm P 5gm or 15gm tube D360
Silver Sulfadiazine Cream 1% w/w U 50gm D474
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Betamethasone Ointment/Cream 0.1% (as vale rate) P 15gm tube D73
Hydrocortisone Acetate Ointment or Cream 1% (as vale rate) P 15gm tube D262
Clotrimazole Betamethasone
+ Neomycine Sulphate
Cream 5 gm P 5 gm tube D590
Lotion or Cream 5% 20gm D68
Gel 2.50% 20gm D69
Salicylic Acid Topical Solution 5% P D468
Podophyllum Resin Cutaneous Solution 10 –2% S D416
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ivermectin Tablet (Scored) 6mg T 1 tab x 10 D296
Cream 5% P 30 g D714
Lotion 1% U 50 ml D715
Fusidic Acid Cream 2% P 10g D645
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Chlorhexidine Solution 5% ( Digluconate)
for dilution
P 100ml bottle D111
Ethanol (Spirit) Cutaneous Solution 70% (denatured) P 100ml bottle D206
10% P 100ml / 500ml / 1litre D421
5% U 100ml / 500ml / 1litre D422
Hydrogen Peroxide Solution 6% w/v P 1litre D264
Surgical Spirit Solution 94% P 100ml / 500ml bolttle D494
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Sodium Hypochlorite Powder for Solution 0.10% P D480
Glutaraldehyde Aqueous Solution 2.00% S 5 litre can D247
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
20mg 10 x 10 D238
40mg 10 x 10 D239
Oral Solution 20mg/5ml D240
Injection 10 mg/ml 2ml ampoule D241
Hydrochlorothiazide Tablet 50 mg P 10 x 10 D260
25 mg S 10 x 10 D482
16. PERITONEAL DIALYSIS SOLUTION— restricted to tertiary care center where peritoneal dialysis is undertaken
18. DIURETICS
Furosemide Tablet P
Spironolactone Tablet
12.6 Lipid Lowering Agent
14. DERMATOLOGICAL MEDICINES (topical)
14.1 Antifungal medicines
14.2 Anti-infective medicines
14.3 Anti-inflammatory and antipruritic medicines
14.5 Scabicides and pediculicides
17. DISINFECTANTS AND ANTISEPTICS
17.1 Antiseptics
17.2 Disinfectants
Povidone Iodine U
Benzoyl Peroxide S
Permethrin
Povidone Iodine Solution
14.4 Medicine affecting Skin Differentitation and Proliferation
S
15. DIAGNOSTIC AGENTS (enlisted in section of Surgical and suture list)
12.5 Drugs used in Eclampsia
Furosemide
Ramipril
P
Tablet S
100mg T 10 x 10 D483
Acetazolamide Tablet 250 mg S 10 x 10 D1
5mg 10x10 D751
10mg 10x10 D752
mannitol IV 100ml T ND6
Triamterene Tablet 25mg T(R) ND28
Chlorthalidone Tablet 12.5mg T(R) ND24
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Xylometazoline Nasal Drop 0.05% Not in
children less than 3
month
T(R) 10ml D535
Tetracaine Hydrochloride Solution 0.50% T D500
Cinnarizine Tablet 25mg T 10 x 10 D121
Hydrogen Peroxide Solution P D264
Chlorhexidine Solution 5% ( Digluconate)
for Dilution
P 10ml D111
Solution (Eye /Ear Drop) 0.3% w/v Sterile
Aqueous
5ml D125
Ointment (Eye/Ear) 0.30% 5gm tube D126
Gentamicin Sulphate Solution (Eye/ Ear Drop) 0.30% P 5ml D244
Sodium bi Carbonate
Glycerine (Soda Bocarb
Glycerine)
Ear Drop 8% P 5ml D477
Neomycin with hydrocortisone Ear Drops 5ml P 5ml D700
Sodium Chloride Nasal Drop 0.60% P 5ml D733
Glucose glycerine Nasal drop S ND2
ichthammol glycerin Ointment S ND3
Mometasone nasal spray T(R) ND18
Betahistine Tablet 8mg T(R) ND22
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Chewable Tablet 500mg
(250mg+250mg
+50mg)
10 x 10 D17
Gel 250mg+250mg+50m
g/5ml
60ml D18
Tablet 150 mg P 10 x 10 D452
Injection 50mg/ 2ml S 2ml ampoule D453
Omeprazole Capsule 20mg P 10 x 10 D382
Pantoprozole Injection 40mg S Vial D400
Sucralfate Syrup 100 ml S 10 ml D738
ursodeoxycholic acid Tablet 300mg T(R) ND30
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 10 mg 10 x 10 D339
Injection 5 mg/ml 2ml ampoule D340
Tablet 10mg 10 x 10 D188
Syrup 1mg/ml 30ml D189
Tablet 10 mg P 10x10 D721
Injection 25 mg/ml in 2-ml
ampoule
P 2ml ampoule D438
5 mg 10 x 10 D435
25mg 10 x 10 D436
Injection 2mg/ml 2ml / 4ml ampoule D384
Syrup 2mg/5ml 30ml D385
Tablet 4mg P 10x10 D706
Doxylamine Succinate Tablet 100mg T 10 x 10 D193
Injection 3mg Ampoule D657
Tablet 1mg 10x10 D656
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydrocortisone Acetate Suppository; Retention
Enema
25 mg S D263
Sulphasalazine Tablet 500 mg S 10 x 10 D493
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 10mg 10 x 10 D172
Injection 10mg/ml 2ml ampoule D173
Ciprofloxacin Hydrochoride P
S
19. EAR, NOSE AND THROAT PREPARATIONS
20. GASTROINTESTINAL MEDICINES
20.1 Antacids and other anti ulcer medicines
20.2 Antiemetic medicines
20.3 Anti-inflammatory medicines
20.4 Antispasmodic medicines
Spironolactone Tablet
TabletTorsemide S
Aluminium Hydroxide+
Magnesium Hydroxide + Active
Dimethicon/Simethicon
U
Ranitidine
Metoclopramide
Hydrochloride
S
Domperidone P
Prochlorperazine Tablet P
SOndansetron
Promethazine
Granisetron IP T(R)
Dicyclomine Hydrochloride P
Tablet 10mg 10 x 10 D269
suppository 20mg/ml D270
Injection 20 mg/ml 2 ml D618
Tablet 40 mg 10x10 D619
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 5mg P 10 x 10 D78
Suppository 10mg S 1x5 pkt D570
Lactulose Syrup 667mg/ml S 60ml D550
15 % w/v 30ml, 20ml plastic ampoule D652
15 %w/v50ml 20ml plastic ampoule D653
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
(Low osmolarity
245mmol/l) 4.1
g/200ml;
Components to
reconstitute 200 ml
of Glucose-
electrolyte solution:
Glucose: 2.7 g;
Sodium Chloride:
0.52 g; Potassium
Chloride: 0.3g;
Trisodium Citrate
Dehydrate*: 0.58 g
1 sachet (200ml) D386
20.5 g/l;
Components to
reconstitute 1 litre of
Glucose-electrolyte
solution: Glucose:
13.5 g/L; Sodium
Chloride: 2.6 g/L;
Potassium Chloride:
1.5 g/L; Trisodium
Citrate dehydrate*:
2.9 g/L
1 sachet (1litre) D387
Zinc Sulphate Dispersible Tablet (Scored) 20mg U 10 x 10 D541
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Betamethasone Dipropionate
+ Phenylephrine + Lignocaine
Ointment 0.025%+0.1%+2.5% P 20gm tube D75
Liquid Paraffin Liquid P 500ml bottle D315
Phenol Liquid S 1 litre/5 litre cane D406
Calcium Dobesilate Capsule 500 mg S 10x10 D576
Calcium Dobesilate+ Lignocain 2%
Ointment 0.25%+3 % S 30 g D577
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydrocortisone Sodium
Succinate
powder for Injection 100 mg P Vial D261
Prednisolone Liquid 5mg/5ml P 120ml bottle D429
Methyl Prednisolone Injection 40mg/ml S 2ml ampoule D336
Methyl Prednisolone Injection 500mg S D336A
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
30 micrograms +
150 micrograms
U 10 x 10 D209
Levonorgesterel Tablet 750mcg P 10 x 10 D303
20mcg+ 150mcg 1x21 D631
30mcg+150mcg 1x21 D632
Ethinylestradiol+ Drospirenon Tablet 30mcg+3mg T 1x21 D633
Depot Medroxy progesteron
acetate
Injection 150mg T Vial D604
Desogestrol Tablet 75mcg P 1x28 D605
20.7 Antihaemorrhoidal medicines Local anaesthetic, Astringent and Anti-inflammatory drug
20.5 Laxatives
20.6 Medicines used in diarrhoea
Enema PGlycerine Sodium Chloride
21.2.2 Intrauterine devices
Hyosine Butyl Bromide P
Drotavarine S
Bisacodyl
Oral Rehydration Salts Powder Sachet U
Ethinylestradiol +
Levonorgestrel
Ethinylestradiol +
Desogesterol
Tablet
Tablet T
21. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
21.1 Adrenal hormones and synthetic substitutes
21.2 Contraceptives
21.2.1 Hormonal contraceptives
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Copper-containing device As per RCH Supply U D141
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Condoms with or without
Spermicide (Nonoxinol)
As per NACO/ RCH supply U D138
Diaphragms with Spermicide
(Nonoxinol)
As per NACO/ RCH supply P D163
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Estradiol Valerate Tablet 2mg S 10 x 10 D207
0.625mg 10 x 10 D139
Estriol succinate Cream 15mg S Tube D628
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
2.5 mg 10 x 10 D245
5 mg 10 x 10 D246
40 IU/ml 10 ml vial D276
100 IU/ml 10 ml vial D277
40 IU/ml 10 ml vial D278
100 IU/ml 10 ml vial D279
Metformin Hydrochloride Tablet 500 mg P 10 x 10 D333
1mg 10 x10 D545
2mg 10 x10 D546
Tablet 2.5mg 10 x10 D547
5mg 10 x10 D548
10mg 10 x10 D549
Premix Insulin 30:70 Injection 40IU/ml T Vial D720
Rapid Acting Insuline
Analogue
Injection 3ml/cart T Vial D728
Biphasic Insuline Analogue
25:75
Injection 3ml/cart T Vial D569
Gliptin Tablet 10x10 T 10x10 D651
vasopressin injection 2ml/vial T ND12
Pioglitazone Tablet 15mg T(R) ND19
Acarbose Tablet 50mg T(R) ND20
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
5mg 10 x 10 D326
10mg 10 x 10 D327
Norethisterone Tablet 5mg S 10 x 10 D374
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
25mcg 10 x 10 D304
50mcg 10 x 10 D305
100 mcg 10 x 10 D306
Potassium Iodide Tablet 60 mg S 10 x 10 D420
50 mg 10 x 10 D442
100 mg 10 x 10 D443
Iodine Solution 8mg/5ml S D280
Carbimazole Tablet 5mg S 10 x 10 D89
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tuberculin, Purified Protein
Derivative (PPD)
Injection P D513
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Antitetanus Immunoglobulin
(Human)
Injection 500 IU S Vial D46
100 mcg single dose prefilled
syringe/ Vial
D44
300mcg single dose prefilled
syringe/ Vial
D45
Polyvalent Snake Antivenom
Serum
Injection 10ml P 10ml Vial D418
10 000 IU Vial D184
Glibenclamide Tablet P
22. IMMUNOLOGICALS
22.1 Diagnostic agents
22.2 Sera and immunoglobulins
21.3 Estrogens
21.4 Insulins and other antidiabetic agents
21.6 Progestogens
Insulin Injection (Soluble) Injection S
Intermediate-Acting Insulin (as
Compound Insulin Zinc
suspension or Isophane
Insulin)
Injection S
Glimipride Tablet T
Glipizide
Tablet (Sustain released)
T
Anti-D Immunoglobulin
monoclonal (Thiomersal free)
Injection S
Diphtheria Antitoxin Injection S
21.2.3 Barrier methods
S
21.7 Thyroid hormones and antithyroid medicines
Conjugated Equine Oestrogen Tablet T
Medroxy Progesterone Acetate Tablet S
Levothyroxine Sodium Tablet S
Propyl Thiouracil Tablet
20 000 IU Vial D185
Rabies Immunoglobulin
Equine
Injection 300 U/ml T 5 ml vial D725
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
BCG Vaccine Injection U Vial D65
Diphtheria,Pertussis and
Tetanus combined (DPT)
vaccine
Injection U Vial D186
Hepatitis B Vaccine Injection 20mcg U 1ml Vial D257
Measles Vaccine Injection U Vial D323
Poliomyelitis Vaccine Oral Drop U D417
Tetanus Vaccine (Tetanus
Toxoid)
Injection U 5ml ampoule D499
MMR (Live Vaccine) Injection P D357
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Anti rabies Vaccine
(Chickembryo)
Injection IM administration 2.5 IU S Vial D42
Typhoid Vaccine Injection T® Vial D759
Pneumococcal Injection T® Vial D716
Hib vaccine Injection T® Vial D658
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
500 micrograms 1ml ampoule D361
2.5 mg 5ml ampoule D362
Suxamethonium Chloride
(Succinylchloline)
Powder for Injection 50 mg/ml S Vial D495
Pancuronium Injection 2mg/ml T 10ml vial D394
Vecuronium Powder for Injection 20mg T Vial D519
Atracurium Injection 10mg/ml T 2.5ml ampoule D54
Tamsulosin Tablet 0.4mg T(R) ND29
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Epinephrine Hydrochloride
(Adrenaline)
Injection 1 mg/ml P 1ml ampoule D199
Atropine Sulphate Injection 0.6 mg/ml S 2ml ampoule D56
Sodium bi Carbonate Injectable Solution
(Intravenous Fluid)
1.4% Isotonic
(equivalent to Na+
167 mmol/l, HCO3-
167 mmol/l)
S D475
Calcium Gluconate Injection 100 mg/ml S 10ml ampoule D84
Dextrose Injectable Solution
(Intravenous Fluid)
10% Isotonic P 250ml/ 500ml D159
Syrup 2 mg/5 ml 100 ml D463
Respirator Solution for use
in Nebulizers
5 mg/ml 15ml D465
Sucrose Solution 24 % T 10ml Ampoule D739
Surfactant porcine Injection 4ml/kg T(R) Vail D741
Injection 20mg/ml 3ml vial D574
Syrup 20mg/ml 3ml vial D575
Indomethacin Injection 1mg T Vial D669
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Gentamicin Sulphate Solution (Eye/Ear drop) 0.30% P 5ml D244
Solution (Eye/Ear Drop) 0.3% w/v sterile
aqueous
5ml D125
Ointment (Eye/Ear) 0.30% 5gm Tube D126
Miconazole Solution (Eye Drop) 1% P 10ml D348
Povidone Iodine Ointment/ Drop 0.60% S D424
Acyclovir Ophthalmic Ointment 3.00% S 5gm tube D9
Ofloxacin Eye drops solution 0.30% P 5ml D551
Tobramycine Eye drops solution 0.30% P 5ml D552
Fluorescein Sodium Strip S D229
Tropicamide Eye Drops Solution 0.50% S 5ml drops D512
Moxifloxacin Eye drops solution 0.5%v/w S 5 ml vial D695
Fluconazole Eye drops solution 0.30% S 5 ml vial D636
Natamycin Eye drops solution 5% T 5 ml vial D697
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
0.50% 5ml D430
1% 5ml D719
24. SPECIFIC MEDICINES FOR NEONATAL CARE
Solution (Eye Drop) S
22.3 Vaccines
Diphtheria Antitoxin Injection S
Neostigmine Metilsulfate Injection S
Ciprofloxacin Hydrochoride P S
Prednisolone Sodium
Phosphate
P
Caffein Citrate T
25.2 Anti-inflammatory agents
22.3.1 For universal immunization (as per NRHM Supply)
22.3.2 For specific groups of individuals
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
25. OPHTHALMOLOGICAL PREPARATIONS
25.1 Anti-infective agents
Salbutamol Sulphate
a
a
Dexamethasone Eye drops solution 0.10% S 5ml D606
Fluoromethalone acetate Eye drops solution 0.10% T 5ml D638
Ketorolac tromethamine Eye drops solution 1% S 5ml D677
Flurbiprofen Eye drops solution 0.03% S 5ml D641
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetazolamide Tablet 250 mg S 10 x 10 D1
2.00% 5ml D412
4.00% 5ml D413
0.25% 5ml D505
0.50% 5ml D506
Brimonidine tatarate Eye drops solution 0.15% T 5ml D573
Dorzolamide Hydrochloride Eye drops solution 2% T 5ml D615
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Homatropine Solution (Eye Drop) 2% P 5ml D258
Phenylephrine Solution (Eye Drop) 4.00% P 5ml D407
Solution (Eye Drop) 1.00% S 5ml D59
Eye ointment 1% P 3gm Tube D542
Tropicamide+Phenylephrine Eye drops solution 0.8%+5% T 5ml D758
Cyclopentolate Eye drops solution 2% S 5ml D594
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Sodium corboxymethyl
Cellulose
Eye drops solution 0.30% T 5ml D734
Hydroxyl propyl methyl
Cellulose
Eye drops solution 0.30% T 5ml D660
Hyaluronidase Injection 75,000IU T 5ml D659
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 125 micrograms 10 x 10 D200
Injection 200 micrograms 1ml ampoule D201
Oxytocin Injection 10 IU P 1ml ampoule D393
Dinoprostone Gel 0.5mg T D183
Carboprost (PGF2α) as
Tromethamine USP (Preservative
Free)
Injection 0.25mg/ml T 1ml ampoule D91
100mcg P 4tab x 10 D353
200mcg U 4tab x 10 D354
Mifepristone Tablet 200mg S 1tab x 10 D352
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Isoxsuprine Injection 5mg/ml S 2ml ampoule D293
20 mg 10 x 10 D294
40 mg 10 x 10 D295
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Tablet 100 mg 10 x 10 D118
Syrup 25 mg/5ml D119
Injection 25 mg/ml 2ml ampoule D120
Fluphenazine Decanoate or
Enantate
Injection 25 mg S 1ml ampoule D231
Tablet 1.5 mg 10 x 10 D249
Tablet 5 mg 10 x 10 D250
Injection 5 mg 1ml ampoule D251
Liquid 2mg/ml 30ml D252
5mg 10 x 10 D380
10mg 10 x 10 D381
Injection 10mg 5ml D705
2mg 10 x 10 D459
3mg 10 x 10 D460
Promethazine Hydrochloride Injection 25 mg/ml P 2ml ampoule D438
Tablet 1mg 10 x 10 D318
Injection 4mg 10 x 10 D319
27. PSYCHOTHERAPEUTIC MEDICINES
27.1 Medicines used in psychotic disorders
26.1 Oxytocics
26.2 Antioxytocics
Pilocarpine Hydrochloride or
Nitrate
Solution (Eye Drop)
Timolol Maleate Solution (Eye Drop)
S
S
25.3 Local anaesthetics see as per section 1.2
25.4 Miotics and antiglaucoma medicines
25.5 Mydriatics
26.6 Lubricating Agents
26. OXYTOCICS AND ANTIOXYTOCICS
Haloperidol S
Atropine Sulphate
Ergometrine Hydrogen
Maleate
P
Misoprostol Tablet
Isoxsuprine Hydrochloride Tablet S
Chlorpromazine Hydrochloride T
TabletOlanzapine
Risperidone Tablet T
Lorazepam T
T
25mg 10 x 10 D25
10mg 10 x 10 D25A
Sertraline Tablet 50mg T 10 x 10 D470
100mg T 10 x 10 D137
50mg S 10x10 D593
50mg 10x10 D723
100mg 10x10 D724
Nortriptyline Tablet 25mg T ND14
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Imipramine Hydrochloride Tablet 25 mg P 10 x 10 D275
Fluoxetine Hydrochloride (for
use above 8 years of age)
Tablet 20mg T 10 x 10 D230
7.5mg 10x10 D691
15mg 10x10 D692
5mg 10x10 D625
10mg 10x10 D626
20mg 10x10 D627
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
200 mg 10 x 10 D86
400 mg 10 x 10 D87
Lithium Carbonate Tablet 300 mg T 10 x 10 D316
200mg 10 x 10 D514
500mg 10 x 10 D515
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diazepam Tablet (Scored) 5 mg P 10 x 10 D165
Triclofos Syrup 500mg/5ml T 30 ml D757
Chlordiasopoxide Tablet 25mg S 10x10 D585
Clonazepam Tablet 0.5mg P 10x10 D588
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Aminophylline Injection 25 mg/ml P 10ml ampoule D22
Epinephrine Hydrochloride
(Adrenaline)
Injection 1 mg P 1ml ampoule D199
2 mg 10 x 10 D461
4 mg 10 x 10 D462
Syrup 2 mg/5 ml 100ml D463
Respirator Solution for use
in Nebulizers
5 mg/ml 15ml D465
MDI (CFC free) 100mcg/dose in 200
doses
200 MDI D466
Capsule (Rotacap) 200mcg 30 Cap D467
Tablet 2.5mg 10 x 10 D497
Injection 0.5mg/ml 1ml ampoule D498
Etiophylline + Theophylline Tablet 77mg + 23mg
(100mg)
P 10 x 10 D212
Theophylline Injection 25mg/ml P 2ml D212A
Ipratropium bromide Inhalation 20mcg/ S 200 MDI D670
Formetrol+Fluticaxone Inhalation 5mcg+50mcg S 150 MDI D643
4mg 10x10 D693
10mg 10x10 D694
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bromhexine Hydrochloride Syrup 4mg/5ml P 60ml D543
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
S
Mirtazepine Tablet T
27.2 Medicines used in mood disorders
27.2.1 Medicines used in depressive disorders
27.2.2 Medicines used in bipolar disorders
27.3 Medicines used in generalized anxiety and sleep disorders
28. MEDICINES ACTING ON THE RESPIRATORY TRACT
28.1 Antiasthmatic medicines
28.2. Anti tussive and expectorants
29. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
29.1 Oral
Valproic Acid (Sodium Salt) Tablet (Control Release) S
Salbutamol Sulphate Tablet P
Terbutaline T
Monteleukast Tablet
Carbamazepine Tablet (Control Release) S
Clozapine Tablet
Escitalopram Tablet T
Quetiapine Tablet T
Amitriptyline Tablet T
(Low osmolarity
245mmol/l) 4.1
g/200ml;
Components to
reconstitute 200 ml
of Glucose-
electrolyte solution:
Glucose: 2.7 g;
Sodium Chloride:
0.52 g; Potassium
Chloride: 0.3g;
Trisodium Citrate
Dehydrate*: 0.58 g
1 sachet (200ml) D386
20.5 g/l;
Components to
reconstitute 1 litre of
Glucose-electrolyte
solution: Glucose:
13.5 g/L; Sodium
Chloride: 2.6 g/L;
Potassium Chloride:
1.5 g/L; Trisodium
Citrate Dehydrate*:
2.9 g/L
1 sachet (1litre) D387
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
5% 250ml/500ml D158
10% Isotonic 250ml/500ml D159
50% Hypertonic 250ml/500ml D160
5% Dextrose, 0.18%
Sodium chloride
(equivalent to Na+
30 mmol/l, Cl- 30
mmol/l)
250ml/500ml D162
5% Dextrose, 0.9%
Sodium chloride
250ml/500ml D161
25% P 250ml/ 500ml D544
Potassium Chloride Injection 11.2% (equivalent to
K+ 1.5 mmol/ml, Cl-
1.5 mmol/ml)
P 20 ml ampoule D419
0.45% Isotonic 250ml/500ml D478
0.9% Isotonic
(equivalent to Na+
154 mmol/l, Cl- 154
mmol/l
250ml/500ml D479
Injection 20ml T Ampoule D732
Sodium bi Carbonate Injectable Solution
(Intravenous Fluid)
1.4% Isotonic
(equivalent to Na+
167 mmol/l, HCO3-
167 mmol/l)
P D475
Sodium Lactate, Compound
Solution (Ringer Lactate
Solution)
Injectable Solution
(Intravenous Fluid)
Each 100ml
contains: Sodium
Lactate 0.32gm,
Potassium Chloride
0.4gm, Sodium
Chloride 0.6gm,
calcium chloride
0.027gm.
U 100ml/500ml D481
Oral Rehydration Salts Powder Sachet U
29.2 Parenteral
Dextrose Injectable Solution
(Intravenous Fluid)
Sodium Chloride
P
P
Injectable Solution
(Intravenous Fluid)
P
Calcium Gluconate Injection 100 mg/ml in 10-ml
ampoule
S D84
Injectable Solution
(Intravenous Fluid)
Electrolyte G (Multi-
Electrolyte with 5%
Dextrose IV Injection Type
III USP
Each 100ml
Contains: Anhydrous
Dextrose 5gm;
Sodium Chloride
0.37gm; Potassium
Chloride 0.13gm;
Ammonium Chloride
0.37gm; Sodium
Sulphite 15mg
P 100ml D194
Each 100ml
Contains: Anhydrous
Dextrose 5 g;
Sodium Acetate
Trihydrate 0.28 g
Potassium Chloride
0.15 g; Dibasic
Potassium
Phosphate 0.13 g
Sodium Chloride
0.091 g
Anhydrous Dextrose
5gm,
Potassium Chloride
0.13gm,
Sodium Acetate
0.32gm,
Dibasic Potassium
Phosphate 0.026gm,
Magnesium Chloride
0.031gm
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
2ml ampoule D532
5ml ampoule D533
10ml ampoule D534
sodium citrate Syrup 100ml S ND1
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ascorbic Acid (Vit C) Tablet (Scored) 100 mg P 10 x 10 D51
Ascorbic Acid (Vit C) Tablet (Scored) 500 mg P 10 x 10 D51A
Iodine Solution 8mg/5ml S D280
1mg 10 x 10 D232
5mg 10 x 10 D233
Tablet 50 000 IU P 10 x 10 D524
Oral Oily Solution 100 000 IU/ml U Multidose Dispenser D525
Thiamine Hydrochloride (Vit
B1)
Injection 50mg S 10ml D502
Riboflavin (Vit B2) Tablet 5mg U 10 x 10 D455
Pyridoxine Hydrochloride (Vit
B6)
Tablet 25 mg P 10 x 10 D447
Multivitamin (B1,B2,B6,
Niacinamide, Pantothenate,
Folic Acid, Ascorbic Acid,
Biotin)
Tablet/ Capsule 10mg + 10mg + 3mg
+ 100mg + 50mg +
1.5mg + 150mg +
100mcg
P 10 x 10 D63
Vitamin B12 (Cyanocobalamin) Injection 500mcg/ml S 5ml ampoule D526
Methylcobalamine Tablet 1500mcg S 10 x 10 D526A
Niacinamide Tablet 50mg U 10 x 10 D365
Vitamin D3 Granules 1gm S Sachet D527
Calcium Salts Tablet 500mg (as elemental
calcium)
U 10 x 10 D85
Multivitamin + Multimineral Syrup P 100ml D696
Pyridoxine Hydrochloride Tablet 50mg P 10x10 D722
Vitamin D3 Drops 400IU T 30ml bottle D761
Zinc Acetate Syrup 20mg T 30ml bottle D763
Vitamin A Palmitate
PInjectionWater for injection
30. VITAMINS AND MINERALS
Folic Acid Tablet S
Electrolyte
100ml
D195Injectable Solution
(Intravenous Fluid)
Electrolyte M (Multi-
Electrolyte with 5%
Dextrose IV Injection Type
III IP)
P 100ml
D196Injectable Solution
(Intravenous Fluid)
Electrolyte P (Multi-
Electrolyte with 5%
Dextrose IV Injection Type
I IP)
Each 100ml
contains:
P
29.3 Miscellaneous
Surgical List Size Unit Pack Facility Code Code
Absorbable gelatine sponge IP 80mmX 50mmX10mm S C1
Absorbent Cotton Woll IP - 700 Gms Roll P C2
7.5cm X 5mts. Spool T C3
7.5cm X 10mts. 4 Rolls T C4
0.00 Nos S C5
0.0 Nos S C6
0 Nos S C7
1 Nos S C8
2 Nos S C9
3 Nos S C10
4 Nos S C11
Adult Nos P C12
Pediatrics Nos P C13
Anesthesia Circuit S C14
Bleached Bandage Cloth Width: Counts
Other Specifications As Per Schedule F(II)
of Drugs and Cosmetics Act 1940
90cm, Length: 20mtrs,
40X40Meters P C15
Bleached Bandage Cloth Width: Counts
Other Specifications As Per Schedule F(II)
of Drugs and Cosmetics Act 1941
Meters P C16
Bone Biopsy Needie Nos T C17
Bone Cement Nos T C18
Bone Narrow Aspiration Needle Nos T C19
Bone Narrow Biopsy Needle Nos T C20
Bone wax T C21
Catheters malecot's Rubber and Latx Nos T C22
Central Vein Catheters Nos T C23
Corrugated rubber/latex Nos T C24
10cm P C25
15cm P C26
16G Nos T C27
18G Nos S C28
20G Nos S C29
22G Nos P C30
23G Nos S C31
24G Nos S C32
26G Nos S C33
23g Nos S C34
24g Nos S C35
12 Nos S C36
14 Nos S C37
2cc Nos P C38
5cc Nos S C39
10cc Nos S C40
20cc Nos S C41
50cc Nos T C42
ECG papers 50mmX20mts S C43
10cm S C44
15cm S C45
Adhesive Plasters USP/Spool Zinc Oxide
Self Adhesive Plaster USP
Airways Guedi
AMBU Bag (Long lasting)
Surgical Products
Crape Bandage
Disposable Needles
Disposable Scalp Vein Set
Disposable Suction Catheter
Disposable Syringes With Needle CGS
Elastoplast
Endotracheal Connectors 2.5 - 10 mm Nos S C46
Endotracheal Tubes (Cuffed) 5.5 - 10 mm Nos S C47
Endotracheal Tubes (Uncuffed) 2.5 - 5 mm Nos S C48
16G Nos T C49
18G Nos T C50
Adults Nos T C51
Pediatrics Nos T C52
16 Nos S C53
18 Nos S C54
20 Nos S C55
22 Nos S C56
24 Nos S C56A
Gigglis Wire Saw S C57
6.1/2 Inches Pair P C58
6 Inches Pair S C59
7.1/2 Inches Pair S C60
7 Inches Pair P C61
5 Nos S C62
6 Nos S C63
8 Nos S C64
10 Nos S C65
Infusion Pump Nos S C66
Adults Nos S C67
Pediatrics Nos S C68
Adults Nos P C69
Pediatrics Nos P C70
14 Nos S C71
16 Nos S C72
18 Nos S C73
20 Nos S C74
22 Nos S C75
24 Nos S C76
26 Nos S C77
Laminaria Tent - Medium Nos S C78
3 Nos T C79
4 Nos T C80
Laryngoscopes Set of 4 Blades Nos S C81
Mackintosh Double Colour Water Proof Meters P C82
Mayo's cutting suture Needle Nos S C83
Medicated Sterile paraffin Gauze 10cmX10cm Nos S C84
Microdrip set 30 drops per ml Nos S C85
Multipara monitor (long lasting) Nos T C86
Needle Hypodermic - Insulin Needle 26G X 1/2 inch Nos S C87
Neonatal Resuscitation Kit Nos S C88
Neonatal Suction tube 10 french Nos S C89
Paper Adhesive Plaster; Micropore 10cm 1"X9.0mts Roll S C90
Paper Adhesive Plaster; Micropore 5cm 1"X9.0mts Roll S C91
Pediatric drip set 60 drop per ml Nos S C92
10cm X 2.7mts / Roll 10 Roll S C93
15cm X 2.7mts / Roll 11 Roll S C94
Polypropyline MESH 15cm X 15cm T C95
Pulse oximeter T C96
Children : 10 Nos S C97
Epidural Set
Flatus Tube
Foley's Urinary Catheter Size
Gloves
Infant feeding tubes
Inter costal drainage Tube (with Under
water seal)
Intravenous Set with Airway and Needle
IV Cannula (Two Way)
Laryngeal Mask Airways
Plaster of Paris Bandages BP
Ryle's Tube (P.V.C.)
Children : 12 Nos S C98
Adult : 16 Nos S C99
Adult : 18 Nos S C100
Adult : 20 Nos S C101
Adult Nos T C102
Pediatrics Nos T C103
Simple Plain Catheters Nos T C104
Skin grafting Blade Nos T C105
22G Nos S C106
23G Nos S C107
24G Nos S C108
25G Nos S C109
Stilletes All Size S C110
Suction Set Nos T C111
11 100 Blades / PacketS C112
15 100 Blades / PacketS C113
22 100 Blades / PacketP C114
23 100 Blades / PacketS C115
Size 11 - 156 Nos/Pkt In
Each SizeS C116
Size 1 - 56 Nos/Pkt In
Each SizeS C117
Size 16 - 206 Nos/Pkt In
Each SizeS C118
Size 6 - 106 Nos/Pkt In
Each SizeP C119
Size 11 - 156 Nos/Pkt In
Each SizeS C120
Size 1 - 56 Nos/Pkt In
Each SizeS C121
Size 16 - 206 Nos/Pkt In
Each SizeS C122
Size 6 - 106 Nos/Pkt In
Each SizeS C123
Tissue Biopsy Needle Nos T C124
Tourniquet PVC/Latex 5cm width Size Nos S C125
16 Nos S C126
18 Nos S C127
20 S C128
Tube Drain PVC Nos S C129
Universal Protection Kit (For Operation of
HIV +ve Patient; NACO)Nos C130
Urinary Drainage Bag Nos P C131
Vaccum Drain Nos S C132
Suture Needles Curved And Cutting
Assorted Pack 1/2 Circle Cutting
Suture Needles Curved And Round Body
Assorted Pack 1/2 Circle RB
Trochar and canula bivalve (Disposable
and Metallic) (For SPC)
Ryle's Tube (P.V.C.)
Sang's Taken Black More tube PVC
Spinal Needle
Surgical Blade
Name of Drug Formulation Strength / Size Facility Code Unit Packs Drug Code
Pregnancy Diagnostic Kit RCH Supply C160
Rapid Diagnostic Kit for malaria
(bivalent)NVBDCP Supply C161
Bivalent RD Kit Test Kit S C139
NS1 Antigen C159
HB color scale for screening C140
Whole blood finger prick test for
HIV screening in emergencyC164
Uristix for albumine and sugar U C162
Viral transport Media Test Kit C163
Diagnostic Agents
Name of Drug Formulation Strength / Size Facility Code Unit Packs Drug Code
Barium SulfateOral Aqueous
Suspension30 - 200% w/v S C133
S 5ml ampoule C141
S 10ml ampoule C142
S 20ml ampoule C143
Powder 3.5 kg C134
Enema 3.5 kg C135
HD 300gm 5x300GMS C136
Paste 200gm 5x300GMS C137
Rapid Transit 125gm 5x200GMS C138
300mg/40ml C146
300mg/50ml C147
350mg/20ml C148
350mg/50ml C149
350mg/100ml C150
370mg/20ml C151
370mg/50ml C152
370mg/50ml C153
370mg/100ml C154
10ml Vial C144
20ml Vial C145
320mg/50ml C155
320mg/100ml C156
270mg/50ml C157
270mg/100ml C158
Non Isosmolar lonic Contrast
Media
lohexol Injection 350 mg Iodine/ml
Radio contrast media
(Please check whether facilities available at secondary level or not accordingly include)
Barium Sulphate
Non Ionic Contrast Media
MRI Contrast media
Surgical List Size Unit Pack Facility Code Code
Chromic with CD RB needle 40mm
Length 75cm1/0 12 Foils T S27
Chromic with 1/2 Cir RB needle
20mm Length 75cm3/0 12 Foils T S22
Chromic with 1/2 Cir RB needle
30mm Length 75cm2 12 Foils T S21
Chromic with 1/2 Cir RB needle
40mm Length 75cm2/0 12 Foils T S23
Chromic with ST RB needle 60mm
Length 75cm1 12 Foils T S29
Chromic with CD cutting needle
12mm Length 70cm3/0 12 Foils T S25
Chromic with Cir RB needle 40mm
Length 75cm2/0 12 Foils T S28
Chromic with CD RB needle 30mm
Length 75cm3/0 12 Foils T S26
Chromic with CD cut needle 26mm
Length 75cm3/0 12 Foils T S24
Suture List
1. Absorbable Sutures.
1.1 Catgut Chromic (With needle)
Surgical List Size Unit Pack Facility Code Code
2/0 12 Foils T S11
1/0 12 Foils T S12
1 12 Foils T S13
2 12 Foils T S14
3/0 12 Foils T S15
3 12 Foils T S86
Catgut Chromic length 150cm
Suture List
1. Absorbable Sutures.
1.2 Chromic (Without needle)
Surgical List Size Unit Pack Facility Code Code
2/0 12 Foils T S16
1/0 12 Foils T S17
1 12 Foils T S18
2 12 Foils T S19
3/0 12 Foils T S20
3/0 12 Foils T S87
Catgut Plain 150cm
Suture List
1. Absorbable Sutures.
1.3 Catgut Plain (Without needles)
Surgical List Size Unit Pack Facility Code Code
3/0 12 Foils T S71
2/0 12 Foils T S72
4/0 12 Foils T S73
Synthetic absorbable sutures with 1/2 CIR
RB needles 30mm length 90cm1/0 12 Foils T S74
Synthetic absorbable sutures with 1/2 CIR T
cut needles (H) 40mm length 90cm1 12 Foils T S78
Synthetic absorbable sutures with 1/2 CIR
RB needles 40mm length 90cm3/0 12 Foils T S75
Synthetic absorbable sutures with 1/2 CIR
cutting needles 36mm length 70cm3/0 12 Foils T S70
2/0 12 Foils T S76
1/0 12 Foils T S77
Synthetic absorbable sutures with CD
cutting needles 22mm length 45cm3/0 12 Foils T S81
Synthetic absorbable sutures with SP MP
DOUBLE needles 8mm length 45cm6/0 12 Foils T S83
Synthetic absorbable sutures with 3/8 CIR
cutting needles 16mm length 45cm4/0 12 Foils T S80
Synthetic absorbable sutures with 3/8 CIR
cutting needles 16mm length 45cm5/0 12 Foils T S79
Synthetic absorbable sutures with curved
reverse cutting needles 12mm length 45cm5/0 12 Foils T S82
1 12 Foils T S88
1/0 12 Foils T S89
2/0 12 Foils T S90
3/0 12 Foils T S91
Synthetic absorbable sutures with 1/2 CIR
RB needles 20mm length 70cm
Synthetic absorbable sutures with 1/2 CIR
RB needles 40mm length 90cm
Poly Glactin
Suture List
1. Absorbable Sutures.
1.4 Synthetic absorbable sutures
Surgical List Size Unit Pack Facility Code Code
2/0 6 Reels T S1
3/0 6 Reels T S2
8/0 6 Reels T S84
10/0 6 Reels T S85
B.B. silk with 3/8 Cir CD with cutting
needle 45mm length 76cm
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.1 BLACK BRAIDED SILK (WITH NEEDLE)
Surgical List Size Unit Pack Facility Code Code
1 6 Reels P S7
2 6 Reels S S8
2/0 6 Reels S S9
3/0 6 Reels S S10
Black braided silk (without needle in reels)
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.2 BLACK BRAIDED SILK
2.2.1 BLACK BRAIDED SILK (WITHOUT NEEDLE IN REELS)
Surgical List Size Unit Pack Facility Code Code
1 12 Foils S S3
2 12 Foils S S4
2/0 12 Foils P S5
3/0 12 Foils S S6
Black braided silk (with needle)
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.2 BLACK BRAIDED SILK
2.2.2 BLACK BRAIDED SILK (WITH NEEDLE IN REELS)
Surgical List Size Unit Pack Facility Code Code
Polyamide black Monofilament length 38cm
size8/0 12 Foils T S36
4/0 12 Foils T S38
3/0 12 Foils T S39
Polyamide with CD Reverse cut needle
12mm length 70cm5/0 12 Foils T S40
Polyamide with 1/2 Cir RB needle 40mm
length 100cm1/0 12 Foils T S37
Polyamide with CD cut needle 16mm length
70cm
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.3 POLYMIDE MONOFILAMENT (NYLON) POLYAMIDE FILAMENT WITH NEEDLE
Surgical List Size Unit Pack Facility Code Code
1/0 12 Foils T S56
2/0 12 Foils T S57
Polypropylene with 1/2 Cir RB needle
40mm length 70cm1 12 Foils T S58
5/0 12 Foils T S53
4/0 12 Foils T S54
Polypropylene with 1/2 Cir RB needle
25mm length 70cm3/0 12 Foils T S55
3/0 12 Foils T S60
2/0 12 Foils T S61
Polypropylene with CD cut RB D needle
16mm length 60cm4/0 12 Foils T S65
Polypropylene with curved cut needle 22mm
length 70cm3/0 12 Foils T S66
Polypropylene with 1/2 Cir RB heavy needle
30mm length 70cm DN 25mm length 90cm1 12 Foils T S59
Polypropylene with cutting needle 45mm
length 100cm1 12 Foils T S67
Polypropylene with 1/2 Cir CC double
needle 13mm length 75cm4/0 12 Foils T S52
Polypropylene with 1/2 Cir Tapper cut
double needle 17mm length 90cm2/0 12 Foils T S62
Polypropylene with 1/2 Cir Tapper cut
needle 25mm length 90cm2/0 12 Foils T S64
Polypropylene with 1/2 Cir Tapper cut
double needle 25mm length 90cm3/0 12 Foils T S63
Polypropylene with 1/2 Cir RB needle
30mm length 70cm
Polypropylene with 1/2 Cir RB needle
16mm length 70cm
Polypropylene with 1/2 Cir Tapper cut DN
25mm length 90cm
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.4 POLYPROPYLENE MONOFILAMENT STERILE PRECUTE LENGTHS
Surgical List Size Unit Pack Facility Code Code
3/0 12 Foils T S30
3/0 12 Foils T S31
Coated polyster Braided green with 1/2 circle
round body double needle 25mm suture length
75cm
3/0 12 Foils T S32
Coated polyster Braided with CD green D needle
17mm (Curved reverse cutting or curved round
body or taper cut) length 90cm
2/0 12 Foils T S33
Coated polyster Braided with CD white D needle
17mm (Curved reverse cutting or curved round
body or taper cut) length 90cm
2/0 12 Foils T S34
Coated polyster Braided with CD white D needle
25mm (Curved reverse cutting or curved round
body or taper cut) length 90cm
2/0 12 Foils T S35
Polybutylate Coated with Polyster Braided
(green) with 1/2 Circle tapercut V-5 17mm
double armed needle, suture length of 90cm with
pledgets size 6X3X1.5cm
2/0 12 Foils T S41
Polybutylate Coated with Polyster Braided
(green) with 1/2 Circle tapercut V-5 25mm
double armed needle, suture length of 90cm with
pledgets size 6X3X1.5cm
2/0 12 Foils T S42
Polyster Braided (green) 5 12 Foils T S68
Polyster Braided (green) 2 12 Foils T S69
Coated polyster Braided (1/2 Cir. RB needle
25mm length 75cm)
Suture List
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
2.5 POLYSTER BRAIDED COATED
Surgical List Size Unit Pack Facility Code Code
Polyglecapron with 1/2 Cir Oval RB Contrast
needle 26mm Length 70cm3/0 12 Foils T S47
Polyglecapron with 1/2 Cir Oval RB JB needle
26mm Length 70cm2/0 12 Foils T S48
Polyglecapron with 3/8 cir cutting needle 25mm 3/0 12 Foils T S49
Polyglecapron with 3/8 cir reverse cutting needle
16mm 4/0 12 Foils T S50
Polyglecapron with curved reverse cutting needle
16mm 5/0 12 Foils T S51
Suture List
3. POLYGLECAPRON SUTURES
Surgical List Size Unit Pack Facility Code Code
Polydioxane with 1/2 Round body heavy needle
40mm, length 90cm1 12 Foils T S43
Polydioxane with 1/2 Cir Reverse cutting
Orthopaedics Surgery (OS) needle 40mm, length
90cm
1 12 Foils T S44
Polydioxane with 1/2 Cir Round body needle
30mm, length 70mm2/0 12 Foils T S45
Polydioxane with 1/2 Cir Round body needle
11mm length 45cm6/0 12 Foils T S46
Suture List
4. POLYDIOXANONE SUTURES
Format to Amend the Essential Drug List for Chhattisgarh
Please indicate the nature of submission by marking the appropriate bracket:
( ) Deletion of a listed drug (Please attach proven evidence of the harmful/
useless effects of the drug.)
( ) Addition of a new drug (Please attach evidence of the proven benefits of
this drug.)
( ) Replacement of a listed drug (Please attach evidence of the proven
benefits of such a replacement over the existing drug.)
Name of Drug (INN) / Generic
Dosage form and Strength
Therapeutic Class
Reason for Amendment
References
Advantages over existing drug(s)in the same therapeutic class
Supporting comparison of newly recommended drug(s) with similar drugs already
available under the specified category in respect of efficacy, safety, suitability and cost
effectiveness:
Drug Efficacy Safety Suitability Cost
Effectiveness
Proposed Drug
Drug available in
existing EDL
Efficacy: This column should summarise potential pharmacological actions duly
supported by data on pharmacodynamics and pharmakokinetics.
Safety: This column should summarise the possible side effects. If possible, the
incidence of frequent side effects and safety margins should be listed.
Suitability: Based on patient related conditions and contraindications. A convenient
dosage form or schedule which may have a strong impact on patient adherence to
treatment.
Cost Effectiveness: Total cost of the treatment rather than cost per unit should be the
guiding factor.
Submitted by :
Address:
Contact Person:
Telephone Number:
Signature: Date:
SUSPECTED ADVERSE DRUG REACTION REPORTING FORM For VOLUNTARY reporting of Adverse Drug Reactions by healthcare professionals
INDIAN PHARMACOPOEIA COMMISSION (National Coordination Centre-Pharmacovigilance Programme of India)
Ministry of Health & Family Welfare Government of India
Sector-23, Raj Nagar, Ghaziabad-201002 www.ipc.nic.in
(AMC/ NCC Use only)
AMC Report No.
Worldwide Unique
A. PATIENT INFORMATION 12. Relevant tests / laboratory data with dates1.Patient Initials
____________
2. Age at time of Event or date of birth ____________
3. Sex M F
4. Weight _Kgs
B. SUSPECTED ADVERSE REACTION 13. Other relevant history including pre-existing medicalconditions (e.g. allergies, race, pregnancy, smoking, alcohol use, hepatic/ renal dysfunction etc)
7. Describe reaction or problem
5. Date of reaction started (dd/mm/yyyy)
6. Date of recovery (dd/mm/yyyy)
14. Seriousness of the reaction
15. Outcomes
C. SUSPECTED MEDICATION(S) S.No 8. Name
(brand and /or generic name)
Manufacturer (if known)
Batch No./ Lot No. (if known)
Exp. Date (if known))
Dose used
Route used
Frequency Therapy dates (if known, give duration)
Reason for use of prescribed for
Date started
Date stopped
i.
ii.
iii.
iv.
S.No As per C
9. Reaction abated after drug stopped or dose
reduced
10. Reaction reappeared after reintroduction
Yes No Unknown NA Reduced dose Yes No Unknown NA If reintroduced dose
i.
ii.
iii.
iv.
11. Concomitant medical product including selfmedication and herbal remedies with therapy dates (exclude those used to treat reaction)
D. REPORTER (see confidentiality section on first page) 16. Name and Professional Address :_
Pin code: E-mail _________
Tel. No. (with STD code): _________
Occupation Signature _________________
17. Causality Assessment 18. Date of this report (dd/mm/yyyy)
Death (dd/mm/yyyy)
Life threatening
Hospitalization/prolonged Disability
Hospitalization-initial
or
prolonged
Congenital-anomaly
Required intervention to prevent permanent impairment / damage
Other (specify)
Hospitalization-initial
or
prolonged
Fatal
Continuing
Hospitalization-initial
or
prolonged
Recovering
Recovered
Hospitalization-initial
or
prolonged
Unknown
Other (specify)
Hospitalization-initial
or
prolonged
ADVICE ABOUT REPORTING
Report adverse experiences with medications
Report serious adverse reactions. A reaction isserious when the patient outcome is: death life-threatening (real risk of dying) hospitalization (initial or prolonged)
disability (significant, persistent or permanent
congenital anomaly
required intervention to prevent permanent impairmentor damage
Report even if: You’re not certain the product caused adverse reaction You don’t have all the details, however, point nos. 1, 5,
7, 8, 11, 15, 16 & 18 (see reverse) are essentiallyrequired.
Who can report: Any health care professional (Doctors including
Dentists, Nurses and Pharmacists)
Where to report: Please return the completed form to the nearest
Adverse drug reaction Monitoring Centre (AMC) or toNational Coordinating Centre
A list of nationwide AMCs is available at:http://ipc.nic.in and also athttp://cdsco.nic.in/pharmacovigilance.htm
What happens to the submitted information:
Suspected Adverse Drug
Reaction
Reporting Form
For VOLUNTARY reporting of suspected adverse drug reactions by
health care professionals
Information provided in this form is handled instrict confidence. The causality assessment iscarried out at Adverse Drug Reaction MonitoringCentres (AMCs) by using WHO-UMC scale. Theanalyzed forms are forwarded to the NationalCoordinating Centre through the ADR database.Finally the data is analyzed and forwarded to theGlobal Pharmacovigilance Database managed byWHO Uppsala Monitoring Center in Sweden.
The reports are periodically reviewed by theNational Coordinating Centre (PvPI). Theinformation generated on the basis of these reportshelps in continuous assessment of the benefit-riskratio of medicines.
The information is submitted to the SteeringCommittee of PvPI constituted by the Ministry ofHealth and Family Welfare. The Committee isentrusted with the responsibility to review the dataand suggest any interventions that may be required.
Pharmacovigilance Programme
of India
for Assuring Drug
Safety
Confidentiality: The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not ex-pected to and will not disclose the reporter’s identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.
National Coordinating Centre
Pharmacovigilance Programme of India
India Pharmacopoeia Commission Ministry of Health & Family Welfare Government
of India Sector-23, Raj Nagar, Ghaziabad-201002
Tel.:0120-2783400, 2783401, 2783392, FAX: 0120-2783311 www.ipc.nic.in
Chhattisgarh : Pt. JNM Medical College,Dr. Rajesh Hishikar [email protected]
09424205700
Essential Drug List-2016, Raipur, Chhattisgarh
List of Participants
No. Name Designation Institution/Organization
1 Dr. A.K. Chandrakar DME Raipur
2 Dr. S.P. Kujur Dean CIMS, Bilaspur
3 Dr. Shashank Gupta HOD, Medicine Pt. JNM Medical College, Raipur
4 Dr. G.P. Soni Prof. & HOD, SPM Pt. JNM Medical College, Raipur
5 Dr. Smt. Abha Singh HOD, Obs & Gyn Pt. JNM Medical College, Raipur
6 Dr. Prabir Chatterjee Executive Director SHRC, Raipur
7 Dr. S.A. Khan HOD (Pharmacology) CIMS, Bilaspur
8 Dr. Smt. S. Phuljhale HOD, Pediatrics Pt. JNM Medical College, Raipur
9 Dr. Pratibha Jain Shah HOD (Anesthesiology) Pt. JNM Medical College, Raipur
10 Dr. Rajesh Hishikar Professor (Pharmacology) Pt. JNM Medical College, Raipur
11 Dr. Nalini Mishra Professor (Obs & Gyne) Pt. JNM Medical College, Raipur
12 Dr. Lakhan Singh Professor (Medicine) CIMS, Bilaspur
13 Dr. S. Phuljhale MS, Orthopedics Pt. JNM Medical College, Raipur
13 Dr. K.S. Shandilya DD (Store), DHS Directorate of Health Services, C.G.
14 Dr. R. R. Sahani Joint Director Directorate of Health Services, C.G.
15 Dr. Rajesh Sharma SPO (Hosp. Ad.), Directorate of Health Services, C.G.
16 Dr. Prashant Sriwastava CMHO District - Durg
17 Dr. H. S. Uraon CMHO District - Raigarh
18 Dr. J P Meshram Civil Surgeon District Hospital, Durg
19 Dr. B.K. Das Civil Surgeon District Hospital, Raipur
20 Dr. P. Beck Associate Professor Pt. JNM Medical College, Raipur
21 Dr. R.K. Siddharth Associate Professor (Surgery) Pt. JNM Medical College, Raipur
22 Dr. Chandrashekhar Shrivastawa Associate Professor Pt. JNM Medical College, Raipur
23 Dr. Harshad Sakle Associate Professor Pt. JNM Medical College, Raipur
24 Dr. Rashmi Thakur Associate Professor Pt. JNM Medical College, Raipur
25 Dr. S. Sudha Associate Professor (Pediatrics) Pt. JNM Medical College, Raipur
26 Dr. V.B. Verma CIMS, Bilaspur
27 Dr. Rajkumar Agrawal General Manager CGMSC, Raipur
28 Mr. Fidius Kerketta Sr. Program Coordinator SHRC, Raipur
29 Mr. Narayan Tripathi Program Coordinator SHRC, Raipur
30 Arun Lal State Consultant Directorate of Health Services, C.G.